The trading price of Glaukos Corporation (NYSE:GKOS) closed higher on Friday, August 06, closing at $51.02, 0.12% higher than its previous close.
Traders who pay close attention to intraday price movement should know that it fluctuated between $46.84 and $51.20. In examining the 52-week price action we see that the stock hit a 52-week high of $99.00 and a 52-week low of $40.08. Over the past month, the stock has lost -33.89% in value.
Glaukos Corporation, whose market valuation is $2.36 billion at the time of this writing, is expected to release its quarterly earnings report Nov 03, 2021 – Nov 08, 2021. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -$0.29 per share this quarter, however they have predicted annual earnings per share of -$1.17 for 2021 and -$0.82 for 2022. It means analysts are expecting annual earnings per share growth of -1.70% this year and 29.90% next year.
Analysts have forecast the company to bring in revenue of $71.37 million for the current quarter, with the likely lows of $69.56 million and highs of $72.8 million. From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue in 2021 is $296.24 million. The company’s revenue is forecast to grow by 31.70% over what it did in 2021.
A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Glaukos Corporation No upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest GKOS has a 100% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned GKOS a recommendation rating is 12. Out of them, 8 rate it a Hold, while 1 recommend Buy, whereas 0 assign an Overweight rating. 1 analyst(s) have tagged Glaukos Corporation (GKOS) as Underweight, while 2 advise Sell. Analysts have rated the stock Hold, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
A quick review shows that GKOS’s price is currently -7.08% off the SMA20 and -27.05% off the SMA50. The RSI metric on the 14-day chart is currently showing 30.89, and weekly volatility stands at 5.52%. When measured over the past 30 days, the indicator reaches 5.10%. Glaukos Corporation (NYSE:GKOS)’s beta value is currently sitting at 1.65, while the Average True Range indicator is currently displaying 3.27. With analysts defining $41.00-$68.00 as the low and high price targets, we arrive at a consensus price target of $52.00 for the trailing 12-month period. The current price is about 19.64% off the estimated low and -33.28% off the forecast high, based on this estimate. Investors will be thrilled if GKOS’s share price rises to $52.00, which is the median consensus price. At that level, GKOS’s share price would be -1.92% below current price.
To see how Glaukos Corporation stock has been performing in comparison to its peers in the industry, here are the numbers: GKOS stock’s performance was 0.12% in the latest trading, and 3.93% in the past year, while AtriCure Inc. (ATRC) has traded 2.80% on the day and positioned 97.15% higher than it was a year ago. Another comparable company Integra LifeSciences Holdings Corporation (IART) saw its stock close 1.48% higher in the most recent trading session but was up 49.40% in a year. Furthermore, Boston Scientific Corporation (BSX) showed an increase of 0.11% on the day while its price kept inclining at 17.97% over the past year. Glaukos Corporation has a P/E ratio of 0. Also in last trading session, the S&P 500 Index has surged 0.17%, while the Dow Jones Industrial also saw a positive session, up 0.41% on the day.
An evaluation of the daily trading volume of Glaukos Corporation (NYSE:GKOS) indicates that the 3-month average is 556.45K.
Currently, records show that 46.31 million of the company’s shares remain outstanding. The insiders hold 1.50% of outstanding shares. However, since the stock’s price has seen -32.21% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.